MARKET SURGERY — All Prescriptions & Medications — Page 8
Practice Code: D82016 | NORWICH, NR11 6BW
Showing results 351-400 of 629
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Azithromycin | 53 | 1,854 | £489 | -58.2% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 53 | 296.8K | £7.4K | +283.9% ▲ |
| Cinnarizine | 52 | 3,538 | £168 | +11.1% ▲ |
| Combined ethinylestradiol 20mcg | 52 | 2,031 | £750 | -0.5% vs avg |
| Ketorolac trometamol | 52 | 260 | £212 | +460.5% ▲ |
| Dipyridamole | 51 | 3,060 | £638 | +98.7% ▲ |
| Formoterol/glycopyrronium/budesonide | 49 | 49 | £2.0K | -18.6% ▼ |
| Fentanyl | 48 | 480 | £2.2K | -53.2% ▼ |
| Linaclotide | 47 | 1,400 | £1.7K | +157.3% ▲ |
| Fenofibrate | 47 | 1,428 | £189 | -51.4% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 47 | 1,339 | £161 | +17.0% ▲ |
| Nebivolol | 46 | 1,078 | £443 | -56.6% ▼ |
| Ciclesonide | 46 | 47 | £1.3K | +212.5% ▲ |
| Goserelin acetate | 46 | 46 | £7.0K | +4.4% ▲ |
| Hydrocortisone acetate | 46 | 1,410 | £265 | -30.3% ▼ |
| Hepatitis A/hepatitis B | 46 | 46 | £1.3K | +172.0% ▲ |
| Metoprolol tartrate | 45 | 2,433 | £925 | -11.3% ▼ |
| Domperidone | 45 | 2,682 | £59 | +26.2% ▲ |
| Oxytetracycline | 45 | 2,968 | £1.2K | +74.2% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 45 | 59 | £830 | -60.3% ▼ |
| Betamethasone esters | 45 | 5,510 | £493 | -25.4% ▼ |
| 45 | 3,692 | £6.3K | +12.8% ▲ | |
| Alverine citrate | 44 | 2,558 | £107 | +6.3% ▲ |
| Indometacin | 44 | 3,108 | £197 | +179.6% ▲ |
| Duloxetine hydrochloride | 42 | 1,036 | £243 | -18.0% ▼ |
| Terbinafine hydrochloride | 42 | 2,085 | £366 | +13.2% ▲ |
| 42 | 1,660 | £7.3K | +62.4% ▲ | |
| Celecoxib | 41 | 2,490 | £147 | -37.9% ▼ |
| Urea | 41 | 15.3K | £733 | -38.6% ▼ |
| Hepatitis A | 40 | 40 | £752 | -47.3% ▼ |
| 39 | 2,160 | £7.8K | +60.1% ▲ | |
| Colestyramine | 38 | 2,900 | £977 | +31.9% ▲ |
| Theophylline | 38 | 2,044 | £1.0K | -54.6% ▼ |
| Glycopyrronium/formoterol | 38 | 38 | £1.1K | +50.2% ▲ |
| Betamethasone sodium phosphate | 38 | 3,141 | £415 | +209.1% ▲ |
| 38 | 96 | £642 | +6.3% ▲ | |
| 38 | 224 | £608 | +57.2% ▲ | |
| Nizatidine | 37 | 1,470 | £766 | +7.5% ▲ |
| Sodium picosulfate | 37 | 11.5K | £945 | +1.9% vs avg |
| Mefenamic acid | 37 | 1,765 | £377 | -18.1% ▼ |
| 37 | 62 | £15 | +210.4% ▲ | |
| Glycerol | 36 | 382 | £71 | +2.6% ▲ |
| Levodopa/carbidopa/entacapone | 36 | 4,252 | £2.2K | +28.7% ▲ |
| Medroxyprogesterone acetate | 36 | 1,489 | £291 | -5.9% ▼ |
| Adapalene and benzoyl peroxide | 36 | 1,695 | £724 | -32.6% ▼ |
| 36 | 810 | £249 | -16.5% ▼ | |
| Phosphates (Rectal) | 35 | 218 | £1.3K | +186.3% ▲ |
| Naloxegol | 35 | 609 | £1.0K | +153.8% ▲ |
| Zinc oxide | 34 | 789 | £96 | +64.3% ▲ |
| 34 | 322 | £745 | -13.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.